The completion of the Human Genome Project will provide much needed insight into the molecular basis of monogenic or complex cardiac disorders. But what are the prospects for using genomic information in diagnosis and treatment of cardiac diseases?
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
International Human Genome Consortium. Initial sequencing and analysis of the human genome. Nature 409, 860–921 (2001).
Roberts, R. et al. Myocardial diseases. Circulation 102, 34–39 (2000).
The international SNP map working group. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409, 928–933 (2001).
Charron, P. et al. Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin binding protien C gene. Circulation 97, 2230–2236 (1998).
Charron P. et al. Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population. Circulation 96, 214–219 (1997).
Schwartz, P.J. et al. Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate: implications for gene-specific therapy. Circulation 92, 3381–3386 (1995).
Martinelli, I. et al. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N. Engl. J. Med. 338, 1793–1797 (1998).
Tesson, F. et al. The influence of the angiotensin-I converting enzyme genotype in familial hypertrophic cardiomyopathy varies with the disease gene mutation. J. Mol. Cell Cardiol. 29, 831–838 (1997).
Agerholm-Larsen, B. et al. ACE gene polymorphism: ischemic heart disease and longevity in 10150 individuals. A case referent and retrospective cohort study based on the Copenhagen city heart study. Circulation 95, 2358–2367 (1997).
Bonne G. et al. Mutations in the gene encoding lamin A/C cause autosomic dominant Emery-Dreyfuss muscular dystrophy. Nature Genet. 21, 285–288 (1999).
Shackleton, S. et al. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nature Genet. 24, 153–156 (2000).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Komajda, M., Charron, P. The heart of genomics. Nat Med 7, 287–288 (2001). https://doi.org/10.1038/85420
Issue Date:
DOI: https://doi.org/10.1038/85420
